BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu Q. Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer. Front Genet 2021;12:825109. [PMID: 35087575 DOI: 10.3389/fgene.2021.825109] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Shao D, Li Y, Wu J, Zhang B, Xie S, Zheng X, Jiang Z. An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma. Front Genet 2022;13:903117. [DOI: 10.3389/fgene.2022.903117] [Reference Citation Analysis]
2 Li Y, He L, Wang Y, Tan Y, Zhang F. N6-methyladenosine methyltransferase KIAA1429 elevates colorectal cancer aerobic glycolysis via HK2-dependent manner. Bioengineered 2022;13:11923-32. [PMID: 35546050 DOI: 10.1080/21655979.2022.2065952] [Reference Citation Analysis]
3 Wanowska E, Samorowska K, Szcześniak MW. Emerging Roles of Long Noncoding RNAs in Breast Cancer Epigenetics and Epitranscriptomics. Front Cell Dev Biol 2022;10:922351. [DOI: 10.3389/fcell.2022.922351] [Reference Citation Analysis]